Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net income	$ 14,500,000	$ 112,800,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	63,300,000	60,500,000
Amortization of debt discounts and issuance costs	1,700,000	1,800,000
Amortization of deferred commissions costs	49,500,000	57,200,000
Asset impairments and lease abandonment charges	57,400,000	5,200,000
Gain on lease modification	(1,500,000)	0
Loss on debt modification and extinguishment	700,000	2,200,000
Equity-based compensation expense	104,200,000	126,900,000
Deferred income taxes	11,000,000.0	68,500,000
Tax receivable agreement remeasurement	9,900,000	(13,800,000)
Provision for bad debt expense	39,300,000	22,000,000.0
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net	69,700,000	(17,700,000)
Prepaid expenses and other current assets	(21,100,000)	(4,500,000)
Deferred costs and other assets, net of current portion	(30,400,000)	(53,000,000.0)
Income tax receivable	(2,900,000)	(2,400,000)
Accounts payable	(17,600,000)	(15,200,000)
Accrued expenses and other liabilities	(64,700,000)	(27,600,000)
Unearned revenue	(22,600,000)	(16,800,000)
Net cash provided by operating activities	260,400,000	306,100,000
Investing activities:
Purchases of short-term investments	0	(145,000,000.0)
Maturities of short-term investments	82,200,000	151,500,000
Purchases of property and equipment and other assets	(41,500,000)	(17,600,000)
Right of use asset initial direct costs	(3,400,000)	0
Cash paid for acquisitions, net of cash acquired	(500,000)	0
Net cash provided by (used in) investing activities	36,800,000	(11,100,000)
Financing activities:
Payments of deferred consideration	(700,000)	(400,000)
Repayment of debt	(4,500,000)	(4,500,000)
Payments of debt issuance and modification costs	(2,100,000)	(2,700,000)
Proceeds from exercise of stock options	0	400,000
Taxes paid related to net share settlement of equity awards	(18,100,000)	(17,000,000.0)
Proceeds from issuance of common stock under the ESPP	2,800,000	4,600,000
Tax receivable agreement payments	(31,600,000)	0
Repurchase of common stock	(542,600,000)	(247,000,000.0)
Net cash used in financing activities	(596,800,000)	(266,600,000)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(299,600,000)	28,400,000
Cash, cash equivalents, and restricted cash at beginning of period	456,200,000	424,100,000
Cash, cash equivalents, and restricted cash at end of period	156,600,000	452,500,000
Supplemental disclosures of cash flow information:
Interest paid in cash	39,600,000	43,000,000.0
Cash paid for taxes	11,900,000	7,500,000
Supplemental disclosures of non-cash investing activities:
Property and equipment included in accounts payable and accrued expenses and other current liabilities	8,900,000	200,000
Equity-based compensation included in capitalized software	$ 4,500,000	$ 4,000,000.0